DAFTAR PUSTAKA

1. Rasjidi I. Epidemiologi Kanker Serviks . Indonesian Journal of Cancer.2009. Vol. III, No.3 2. Daniel Tena Gómez, Juana López Santos.HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER: PATHOGENESIS AND EPIDEMIOLOGY.

Communicating Current Research and Educational Topics and Trends in Applied Microbiology A. Méndez-ilas(Ed)2007. 3. Hera Noviana. Human Papillomavirus dan Kanker Serviks. Kalbe Genomics Laboratory. CDK-189/ vol. 39 no. 1, th. 2012 4. Ervin Adam, MD, Zuzana Berkova, PhD,a Zuzana Daxnerova, PhD,a Joseph Icenogle, PhD,c.William. Reeves, MD and Raymond H. Kaufman, MD. Papillomavirus detection: Demographic and behavioral characteristics influencing the identification of cervical disease. American Journal of Obstetrics and Gynecology. FEBRUARY 2000; volume 182 number 2 5. Eileen M. Burd. Human Papillomavirus and Cervical Cancer. Clin Microbiol Rev. 2003 January; 16(1): 1–17. doi: 10.1128/CMR.16.1.1-17. 6. Britt K. Erickson, MD; Ronald D. Alvarez; Warner K. Huh GENERAL GYNECOLOGY Human papillomavirus: what every provider should know. www.AJOG.com.2012 7. Meshkat, Z., Hassan, Z.M., Soleimanjahi, H., Mahmoodi, H., Mirshahabi , H., Farhadi Langeroudi, M. Detection of human papillomaviruses type 16 and 18 by PCR and RFLP in paraffin-embedded cervical cancer tissue specimens Archives of Razi Institute, Vol. 61, No. 3, Autumn (2006) 159-165 8. Wilyman J. The pathogenesis of Human Papillomavirus (HPV) in the development of cervical cancer: are HPV vaccines a safe and effective management strategy? The Health Hazards of Disease Prevention. BSEM March 2011. 9. Michelle S. Longworth and Laimonis A. Laimins .Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol. Mol. Biol. Rev. 2004, 68(2):362. DOI: 10.1128/MMBR.68.2.362-372.2004.

S. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Muller. Obstet. Z. 2nd edition (June 28. Human papillomavirus infections among couples in new sexual relationships. WHO. C. Hunt. Gynecol. C.A. 1991.K. and L.cancerresearchuk. Annie N. doi:10. Tarik Gheit. Tsun. Ngan. N. M.M. Chow. 60:1445–1456 18.com. M.Y.Biophys.10. C. J. Adam. Kjaer SK. 182:257–264 20.1128/JCM. 1995. Cancer Epidemiol Biomarkers Prev 2001. Daxnerova. Burchell AN. et al. U. Volpers. World Cancer Factsheet. P.E.02105-12 12.A. C. Kaufman. Sapp. Giorgia Casalicchio . and J. 19. W.1128/JCM. Sandrine McKay-Chopin. and R. Virol.C. Daxnerova.05933-11 11.C. 16.. W. Am.. Tellier PP. L. Streck. Massimo Tommasino. Berkova. Ball (Eds) Academic Press.J. Adam. H. Chackerian B. Clin. 17. Comparison of GenoFlow HPV test and Linear Array in an Asian Screening Population. Journal of Infectious Diseases 183. R. Structures of bovine and human papillomaviruses. 15. 257 (2000). Peyton. W. W. T. J. Franco EL. Coutlee F. H. M.S. E. Brown. Cheung1. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease. Z. C. E. Mayo. Icenogle. Epidemiology 2010. 1162 pp.J. Zhao. E.21:31-7. Lo.L. Apple. Oscar Gee-Wan Wong. Baker. Z. Gravitt. Fauquet.Kaufman. oi:10. W. Gen. Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. . Icenogle. J. Analysisby cryoelectron microscopy and three-dimensional image reconstruction. Newcomb.10: 101-6 14. Desselberger. Joanne N. Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses Claude . 1554 (2001). van den Brule AJ.H. Obe K. Olson. et al.2012 13. Comparison of Hybrid Capture 2. Berkova. 2012. American Journal of Obstetrics and Gynecology 182. Michelle Iannacone. Hanley J. Stephanie S. 2005) . R.L. Cowsert. Microbiol. Maniloff. Elaine Szeto.S.ISBN: 0122499514 . Clin. J. Hundley.J. and R. 2000. 76:2407–2412. J. J. Linear 1 Array and a bead-based multiplex genotyping assay for the detection of Human Papillomavirus in negative Pap tests and Atypical Squamous Cells of Undetermined Significance. www. Hextan Y. C. Z. Liu. Reeves. M. Microbiol. Reeves and R.. Manola Comar.K. M. Olson. 2012.

Petrovichev N. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. Demers. Syrja¨nen. Wazer DE. A review of human carcinogens—part B: biological agents.25. Melendy A.M. Eur. Vaccarella S.21. 1991. 29. 2000. J. Merlin. J Adolesc Health 2008. 21:168–172.10:321-2. Age-specific prevalence of infection with human papillomavirus in females: a global review. J.e21-41. Onnis. Pimenta JM. Ann. G. Del Mistro. C. Gonzalez P.37:536-46 . W. and D. A. M. Med. Band V. New concepts on the role of human papillomavirus in cell cycle regulation. 28. S. Int J Epidemiol 2008. 23. Anderson. Smith JS.43(4 Suppl):S5. Syrja¨nen. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res 1996. Trottier H. 22. 26. Boyer SN. 31:175–187. et al. A.70:8569-77. 113 (2002) 24. A. Rana RK. et al. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitinproteasome pathway. Smoking and human papillomavirus infection:pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010. et al.19:3044-54. Thomas M. Bouvard V. G... 32. Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Virol. Galloway. Halbert. Snijders PJ. 31. Oncogene 1999. Lancet Oncol 2009. 1999. F. Herrero R. Syrjanen K. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Colposcopy. Torrisi. Gynecol. and K. L. Eur J Epidemiol 2007. J. Cancer Res 2010. L.18:7690-70 25. Oncol. Rodriguez AC.22:723-35.56:4620-24. Clinical Microbiology Newsletter 24. et al. 27.. S25. Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN. Pim D. and D. Straif K. Shabalova I. Bertorelle. cytology and HPV testing in HIV-positive and HIV-negative women. Thomann P.et al. Ferreira S. 65:473–478. Hildesheim A. Banks L. Minucci. 30. Baan R. A. R.

44. Holowaty. Reeves and R. P.Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. S. Miller. J Clin Virol 47:38-42. JAMA 271:1866–1869. M. K. Khiri. P. N. K. Icenogle. Natl. S. J. McDuffie K. A. A. International Journal of Cancer 55. F. Farokh. 39. R. Adam. P. 36. 14:859-70. L. Cheung. Berkova. Kurman. riboflavin. and M. Wright. JAMA 283:81–86. et al. Rakhshan. Noeller. D... 34. Benmoura. A. R. Kazemi. Lyytikainen E. S. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay. Cancer Inst. Ault KA. T.33. D. 40. Chan. 42. Wilkens LR. Interim guidelines for management of abnormal cervical cytology. Sex Transm Infect 2011. 257 (2000). Kaufman. D. Y. and Shahsavan. K. 228. To. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.1993. American Journal of Obstetrics and Gynecology 182. and M. Lehtinen M. Liu. Howley. Riggio. C. Z. Lorincz. 35.H. Ryd W. Denny. J Clin Microbiol 48:756764 43. B. E. L. Rohan. Henson.. Penaranda. 1999. H. B. The 1992 National Cancer Workshop. Silins I.116:110-5. and vitamin B12. Halfon. A. Sandri.. Ngan. Maleknejad. Goodman MT. Int J Cancer 2005. thiamin. E. Leung. et al. 41. The Molecular Basis of the Cancer. 1995.87:372-6 37. G. H.. 1994. L. Detection of human papillomavirus types 16 and 18 in pathologic samples from pationts with cervical cancer by PCR and RFLP methods.. and T. P. DARU 14 (2): 78-81. W.C. Diet and premalignant lesions of the cervix: evidence of a protective role for folate.Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay by comparison with Roche Linear Array HPV genotyping assay. HPV DNA Testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Chlamydia trachomatis infection and persistence of human papillomavirus. Pollack. T. Strand A. T.. Z. Hernandez BY. J. Blanc. Natural dysplasia of the uterine cervix. 91:252–258. Kuhn.. 38. (2006a). and A. L. J. Mendelshon. Cancer Causes Control 2003. Herbst. M. Daxnerova. 2009. 2010. Israel.. and H.Kamemoto L. 2000. Schiffman. . J. B. Liottal. Philadelphia: WB Saunders Co. C.